title: Shock-resistant ventricular fibrillation.
authors.affiliation: Department of Cardiology, Royal Prince Alfred Hospital, NSW, Australia.
authors.forename: Justin
authors.initials: J
authors.lastname: Ghosh
authors.affiliation: Department of Cardiology, Royal Prince Alfred Hospital, NSW, Australia; University of Sydney, NSW, Australia.
authors.forename: Mark A
authors.initials: MA
authors.lastname: McGuire
authors.affiliation: Department of Cardiology, Royal Prince Alfred Hospital, NSW, Australia; University of Sydney, NSW, Australia.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Kilborn
authors.affiliation: Department of Cardiology, Royal Prince Alfred Hospital, NSW, Australia; University of Sydney, NSW, Australia.
authors.forename: Suresh
authors.initials: S
authors.lastname: Singarayar
authors.affiliation: Department of Cardiology, Royal Prince Alfred Hospital, NSW, Australia; University of Sydney, NSW, Australia.
authors.forename: Caroline
authors.initials: C
authors.lastname: Medi
authors.affiliation: Department of Cardiology, Royal Prince Alfred Hospital, NSW, Australia; University of Sydney, NSW, Australia. Electronic address: raymond.sy01@gmail.com.
authors.forename: Raymond W
authors.initials: RW
authors.lastname: Sy
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004554:Electric Countershock; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D006801:Humans; D017211:Treatment Failure; D014693:Ventricular Fibrillation / Q000628:therapy*; D055815:Young Adult
chemical_list: D000889:Anti-Arrhythmia Agents; D005424:Flecainide
keywords: Defibrillation; Flecainide; Idiopathic ventricular fibrillation